Welcome to our dedicated page for Mr Cooper Group SEC filings (Ticker: COOP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a mortgage servicer’s performance means untangling pages of escrow accounting, advance obligations, and MSR valuation tables. Mr. Cooper Group’s filings are no exception—each 10-K outlines nuanced servicing cash flows, while every 10-Q updates pre-payment and delinquency trends investors watch closely. If you’ve ever searched, “Mr. Cooper insider trading Form 4 transactions” or wondered how to read a “Mr. Cooper quarterly earnings report 10-Q filing,” you know the challenge.
Stock Titan solves it. Our AI reviews every submission to EDGAR and delivers plain-English explanations within minutes. Want Mr. Cooper Form 4 insider transactions real-time? We surface the exact trades and flag patterns. Need “Mr. Cooper annual report 10-K simplified”? Our summaries highlight MSR valuation methods, servicing fee revenue, and risk factors in clear language. Even sudden disclosures—think “Mr. Cooper 8-K material events explained”—arrive with instant context, so you grasp the impact before the market reacts.
The platform covers every document type investors ask for:
- 10-Q and 10-K earnings tables with AI-driven variance analysis
- Form 4 alerts that track Mr. Cooper executive stock transactions Form 4
- DEF 14A proxy materials—your guide to “Mr. Cooper proxy statement executive compensation” details
- 8-K items on bulk MSR acquisitions or leadership changes
Whether you’re “understanding Mr. Cooper SEC documents with AI” or performing deeper “Mr. Cooper earnings report filing analysis,” our real-time updates and concise expert notes let you focus on decisions instead of document dumps.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.